Catheter with valve

- Covidien LP

A catheter including one or more bidirectional valves is provided. The catheter includes a tubular body having proximal and distal ends, and inner and outer surfaces, and at least one valve formed near the distal end of the tubular body. The valve includes a deformation portion that defines a slit that is openable and closable. The openable/closable slit communicates from the inner surface to the outer surface of the tubular body, wherein the distance between the inner surface and the outer surface of the tubular body progressively becomes thinner approaching the openable/closable slit within the deformation portion.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
BACKGROUND

1. Technical Field

The present invention relates to a catheter with one or more valves capable of passing a liquid from the interior to the exterior of the catheter or passing a liquid from the exterior to the interior of the catheter via the one or more valves.

2. Background of Related Art

Catheters have been placed in the body of a patient and used to supply anticancer agents, nutritional formulations, or other such items into a patient's vein either temporarily or on a long-term basis. To infuse a stabilized drug solution with the use of a catheter in this fashion, it is important that infection and complications be prevented, that the catheter not break or move, and that the catheter also does not become occluded. However, when a catheter with an open tip is used, blood sometimes enters the catheter, coagulates, and the catheter becomes occluded. To prevent occlusion of catheters from such blood coagulation, the interior space of the catheter is generally filled with physiological saline including added heparin; however, this practice is problematic in that it complicates procedures when a catheter is placed in the body of a patient and represents a burden on health care providers and patients.

Consequently, a catheter including a valve able to prevent occlusion of the catheter due to coagulation of blood has been developed (e.g., see Japanese Unexamined Patent Application Publication S60-58167) by eliminating the tip opening and providing a valve which is normally closed and opens only at times such as when a drug solution is infused between the inside and the outside of the catheter or when blood is collected. Such a catheter with valve (bidirectional valve) is made from an elastic, plastic material, the tip is closed, and at the tip there is formed a linear slit. As a result, when a predetermined pressure differential develops between the inside and outside of such a catheter with valve, the slit opens, and a drug solution can be infused into a vein, or blood within a vein can be released into the catheter and collected. When a predetermined pressure differential between the inside and outside of a catheter with the valve has not developed, the slit is closed, and there is consequently no coagulation of blood within the slit.

Nonetheless, when a drug solution flows from the inside to the outside of a conventional catheter with valve described above, the slit closes with comparative ease, but a problem exists in that when blood flows from outside toward the inside of the catheter with the valve, the opposing surfaces which form the slit are subject to contact pressure, and it is difficult for the slit to open.

Therefore, it would be beneficial to have a catheter with a valve capable of providing a smooth the flow of a liquid both when a liquid flows from the inside toward the outside of the catheter, and when a liquid flows from the outside toward the inside of the catheter.

SUMMARY

Accordingly, a catheter with one or more bidirectional valves is provided. The catheter includes a tubular body endowed with elasticity and plasticity and the tip of which is closed, and in which a valve passing from the inside surface to the outside surface of the tubular body and provided with a slit able to open and close is formed at the tip of the tubular body. The outer circumferential portion of the slit in the valve includes a bidirectional deformation part which, when a liquid passes via the valve from the interior to the exterior of the tubular body, or when a liquid passes via the valve from the exterior to the interior of the tubular body, is easily deformed by the pressure of a liquid toward either the outside or the inside of the tubular body and opens the slit.

The outer circumferential portion of the slit includes a bidirectional deformation part which is easily deformed by the pressure of a liquid toward either the outside or the inside of the tubular body and opens the slit. As a result, the slit is made to open easily not only when a liquid flows from the inside toward the outside, but also when a liquid flows from the outside toward the inside of the catheter with valve, and the flow of a liquid in both inward and outward directions can be made smooth. Additionally, when the pressure differential between the inside and the outside of the catheter with valve is small, the slit is maintained in a closed status by the elasticity of the bidirectional deformation part.

The slit may be formed so as to extend along the axial direction of the catheter with valve, but the slit may also be extended in a direction oblique to the axial direction of the catheter with valve, or extended so as to be perpendicular thereto. The tubular body may be formed in a circular tube shape, and the bidirectional deformation part may be provided by creating a shape differing from other portions formed in the circular tube shape of the catheter with valve or by making the deformation part more flexible than other parts of the catheter. The liquid pertaining to the present disclosure is, for example, an anticancer agent, nutritional agent, or other such drug solution; blood or the like; or a liquid in infused into a vein or taken from a vein of a patient, and hereinafter, a liquid flowing from the inside toward the outside of the catheter with valve is described as a drug solution, and a liquid flowing from the outside toward the inside of the catheter with valve is described as blood.

In an alternative embodiment, bidirectional deformation part and the outer circumferential portion of the slit are provided by being made to project to the inside of the tubular body. As a result, when blood flows from the outside to the inside of the catheter with valve due to blood collection or checking for regurgitation, the blood places pressure on the bidirectional deformation part from a recessed surface side, and the slit opens easily. As a result, the flow of blood from the outside toward the inside of the catheter with valve is made smooth. When a drug solution flows from the inside toward the outside of the catheter with valve to supply said solution to the vein of a patient, the drug solution places pressure on the bidirectional deformation part from a projecting surface side, but in such case, infusion of the drug solution is performed by use of an injection syringe or supply device.

In another embodiment, the bidirectional deformation part is provided by making the outer circumferential portion of the slit thin-walled. As a result, the bidirectional deformation part is easily deformed for the fact of being made thin-walled, and when a drug solution flows from the inside toward the outside, or when blood flows from the outside toward the inside of the catheter with valve, in either case, the slit opens easily, and the flow of drug solution or blood toward its respective direction of orientation can be made smooth. In this instance, the thin-walled bidirectional deformation part may be provided by forming oblique surfaces such that the sides of the slit gradually become thin-walled; by forming a groove-shaped, thin-walled portion at a part maintaining a predetermined interval from the slit; or by making the entire part thin-walled.

When a thin-walled bidirectional deformation part is provided by forming oblique surfaces, opposing surfaces trapping and confronting the slit in the catheter with valve are provided with a required contact width for closing the slit when the pressure differential between the inside and outside of the catheter with valve is below a predetermined level. The oblique surfaces and groove-shaped, thin-walled part may also be provided at the inner circumference or outer circumference of the bidirectional deformation part, or at both the inner circumference and outer circumference.

In yet another embodiment, the bidirectional deformation part is provided by forming oblique surfaces on the outer circumference or inner circumference of parts opposed across the slit in the tubular shape, such that the slit side gradually becomes thin-walled. As a result of this configuration, when a drug solution flows from the inside toward the outside, or when blood flows from the outside toward the inside of the catheter with valve, in either case, the slit opens easily, and the flow of drug solution or blood toward its respective direction of orientation can be made smooth. In this instance, when an oblique surface is formed at the outer circumference, and blood thereby flows from the outside toward the inside of the catheter with valve, the slit opens more easily, and when an oblique surface is formed at the inner circumference, and a drug solution thereby flows from the inside toward the outside of the catheter with valve, the slit opens more easily. In these instances too, opposing surfaces trapping and confronting the slit in the catheter with valve are provided with a required contact width for closing the slit when the pressure differential between the inside and outside of the catheter with valve is below a predetermined level.

In still another embodiment, a plurality of valves provided with a slit and a bidirectional deformation part is formed. As a result, the provision of a plurality of valves allows more reliable inflow of drug solution or outflow of blood through the valve. For example, even if one valve is clogged, infusion of drug solution or outflow of blood can be accomplished through other valves. The plurality of valves in this instance may include an identical item or different items.

In still yet another embodiment, the plurality of bidirectional deformation parts provided with a plurality of valves includes a bidirectional deformation part provided by forming an oblique surface such that a predetermined slit side at the outer circumference of confronting portions across a predetermined slit among a plurality of slits forms an oblique surface that gradually becomes thin-walled, and a bidirectional deformation part provided by forming an oblique surface such that another slit side at the inner circumference of confronting portions across another slit among the plurality of slits forms an oblique surface that gradually becomes thin-walled.

As a result, when blood flows from the outside toward the inside of the catheter, a bidirectional deformation part provided by forming an oblique surface at the outer circumference is easily deformed at the inner circumference, and when a drug solution flows from the inside toward the outside of the catheter with valve, a bidirectional deformation part provided by forming an oblique surface at the inner circumference is easily deformed at the outer circumference. When a drug solution flows from the inside toward the outside of the catheter, and when blood flows from the outside toward the inside of the catheter with valve, in both cases, the flow of drug solution or blood can be made smooth.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a planar view illustrating a catheter according to an embodiment of the present disclosure;

FIG. 2 is a cross-sectional view of 2-2 in FIG. 1;

FIG. 3 is a descriptive view illustrating a catheter placed in the body of a patient;

FIG. 4 is a cross-sectional view illustrating the tip-side portion of a catheter according to an alternative embodiment of the present disclosure; and

FIG. 5 is a cross-sectional view illustrating the tip-side portion of a catheter according to another embodiment of the present disclosure.

 DETAILED DESCRIPTION OF EMBODIMENTS

Catheters according to embodiments of the present disclosure are described in detail hereafter with the use of drawings. FIGS. 1 and 2 illustrate a first embodiment of a catheter with valve shown generally as catheter 30. Catheter 30 is used to supply an anticancer agent, nutritional agent, or other such drug solution into a vein (e.g., B1-B3) of a patient A (see FIG. 3). A port 17 is connected to a base terminal 11 before catheter 30 is placed in the vein of the patient A. Catheter 30 includes a long, thin tubular body made from a flexible polyurethane resin and endowed with elasticity and plasticity. A dome-shaped wall portion 12 is formed at the tip of the catheter 30, and the tip of catheter 30 is closed by this wall portion 12. Wall portion 12 is made from a polyurethane or silicone softer than the body of catheter 30 and is attached to the body of catheter 30 by adhesion or deposition.

A valve 33 with a long, thin elliptical shape in planar view (attitude in FIG. 1) along the axial direction (lengthwise direction) of the catheter 30 is formed at an area of the catheter 30 more toward the base terminal 11 than the wall portion 12 on the circumferential surface of the catheter 30. Valve 33 includes a linear slit 34 extending along the axial direction of catheter 30, and a bidirectional deformation part 35 formed around slit 34. Bidirectional deformation part 35 is provided by forming oblique surfaces at the outside of parts opposed across slit 34 in catheter 30, such that sides defining slit 34 gradually become thin-walled. Bidirectional deformation part 35 forms a recess with a nearly triangular cross-sectional shape provided with two oblique surfaces projecting to the outside of the catheter 30.

Slit 34 is opened by deformation of the bidirectional deformation part 35 when the force applied perpendicular to bidirectional deformation part 35 reaches a predetermined value or higher, for example, 50-60 cmH2O. If the force applied to bidirectional deformation part 35 is below a predetermined value, the elasticity of bidirectional deformation part 35 provides close contact of the confronting surfaces that form slit 34, and slit 34 is thereby closed. Bidirectional deformation part 35 can be formed in various ways; for example, once a tubular catheter with a closed end portion is formed, a heat gun or the like can be used on the tip portion thereof to apply an appropriately heated gas, thereby forming the oblique surfaces that include bidirectional deformation part 35.

Otherwise, an appropriately heated metal rod can be pressed against the tip-side portion of a tubular catheter with a closed tip portion to form the oblique surfaces that define bidirectional deformation part 35, or a tubular catheter with a closed tip portion can be covered with shrink tubing, and the oblique surfaces that define bidirectional deformation part 35 can be formed by shrinking a portion of such tubing. Bidirectional deformation part 35 may also be formed at the same time that a tubular catheter with a closed tip portion is formed. Slit 34 may be formed by cutting along the lengthwise direction in the center of bidirectional deformation part 35.

With reference now to FIG. 3, when catheter 30 is used to supply a drug solution to the vein of a patient A, first, the port 17 is connected to the base terminal 11 of catheter 30. Port 17 is formed by a septum 19 attached to the surface of a circular, plate-shaped unit 18, forming an open space (not illustrated) in the interior. Septum 19 includes a material able to be pierced by a needle and endowed with the property that when the needle is withdrawn, the hole created by the needle is blocked. Consequently, when septum 19 in port 17 is pierced by the needle of a syringe filled with a drug solution, and the drug solution flows from the syringe into port 17, the drug solution passes from the space in port 17 into the interior of catheter 30 and flows outward from slit 34.

As shown in FIG. 3, catheter 30, to which port 17 is connected, may be inserted into a vein from the chest region C of patient A or inserted into a vein from an arm D of patient A. When catheter 30, with port 17 connected, is inserted from the chest region C into a vein, a region near a vein in chest region C, for example subclavian vein B1, is incised, catheter 30 is inserted from subclavian vein B1 located in the vicinity thereof, and the tip-side portion thereof reaches superior vena cava B2. Port 17 is then embedded beneath the chest skin.

When catheter 30 with port 17 attached is inserted into a vein from an arm D, the upper portion of arm D is incised, catheter 30 is inserted from brachial vein B3 located in the vicinity thereof, and the tip-side portion of catheter 30 reaches superior vena cava B2 from subclavian vein B1. Port 17 is then embedded beneath the chest skin. In either case, the interior of catheter 30 and port 17 are filled with physiological saline. The interior pressure and exterior pressure on catheter 30 are therefore nearly equal, and the closed status of slit 34 is maintained.

When a drug solution is supplied into the vein of patient A through catheter 30 with port 17 connected, the needle of a syringe filled with a drug solution is first inserted from the skin surface, septum 19 is pierced, and the tip of the needle is positioned within port 17. The drug solution is then infused from the syringe into port 17. The drug solution thus passes from the interior of port 17 into catheter 30 and enters superior vena cava B2 from slit 34. In this instance, the pressure applied to the drug solution by the syringe is greater than the pressure of blood within superior vena cava B2, bidirectional deformation part 35 is thereby easily deformed toward the outside of the catheter 30, and slit 34 is opened.

When blood is collected or a check is made for regurgitation, the needle of a syringe from which internal air has been expelled is inserted from the skin surface, and septum 19 is pierced. Then with the tip of the syringe located in port 17, the plunger of the syringe is withdrawn. Blood within the vein thus passes from the superior vena cava B2 through slit 34, and enters the interior of the catheter 30. In this instance, the suction force of the syringe easily deforms bidirectional deformation part 35 toward the interior of catheter 30, and slit 34 is opened. In this manner, slit 34 is easily opened both when a drug solution is supplied from the catheter 30 into a vein and when blood within a vein is withdrawn to the inside of the catheter 30, and the flow of the drug solution or blood is made smooth. When a drug solution is not being infused or blood is not being withdrawn by a syringe, the return force produced by the elasticity of bidirectional deformation part 35 also maintains slit 34 in closed status. Slit 34 opens easily not only when a drug solution flows from the inside toward the outside of the catheter, but also when blood flows from the outside toward the inside of the catheter 30, and the flow of a drug solution or blood can be made smooth.

Bidirectional deformation part 35 is deformed by additional pressure or reduced pressure derived from operation of a syringe, and slit 34 opens easily, but when blood flows from the outside toward the inside of catheter 30, the blood puts pressure on bidirectional deformation part 35 from the recess side, and slit 34 therefore opens even more easily. If the pressure differential between the inside and outside of catheter 30 is small, slit 34 is maintained in closed status by the elasticity of bidirectional deformation part 35. At such time, the opposing surfaces that form slit 34 in catheter 30 are in a state of contact with each other, and consequently there is no coagulation of blood within slit 34.

With reference now to FIG. 4, the cross-section of the tip portion of a catheter 30a according to an alternative embodiment of the present disclosure is illustrated. Catheter 30a includes a bidirectional deformation part 35a of a valve 33a provided by forming oblique surfaces at the inner circumference of portions opposed across a slit 34a in catheter 30a, such that the sides defining slit 34a gradually become thin-walled. The structure of other portions of catheter 30a is identical to that of the catheter 30 described above.

When the catheter 30a is used to supply a drug solution into a vein of a patient A, the same procedure as described above can be performed, in which a catheter 30 was used to supply a drug solution into a vein of a patient A. As a result, when a drug solution flows from the inside toward the outside of the catheter, and when blood flows from the outside toward the inside of the catheter 30a, in either case, the slit 34a opens easily, and the flow of drug solution or blood toward its respective direction of orientation can be made smooth. The formation of oblique surfaces at the inner circumference adjacent slit 34a as in the catheter 30a allows the slit 34a to open more easily when a drug solution flows from the inside toward the outside of the catheter 30a. Other operational effects of the catheter 30a are similar to the operational effects of the catheter 30 described above.

Turning now to FIG. 5, a cross-section of the tip-side portion of a catheter 40 according to another embodiment of the present disclosure is illustrated. Catheter 40 includes a plurality of valves 43a, 43b formed at regular intervals along the circumference. As shown, catheter 40 includes two (2) valves 43a and two (2) valves 43b disposed alternately about the circumference of catheter 40. Bidirectional deformation part 45a of valves 43a is provided by forming oblique surfaces at the outer circumference of portions opposed across the slit 44a in catheter 40 such that the sides defining slit 44a gradually become thin-walled. Bidirectional deformation part 45b of valve 43b is provided by forming oblique surfaces at the inner circumference of portions opposed across the slit 44b in catheter 40 such that the sides defining slit 44b gradually become thin-walled.

The structure of other portions of the catheter 40 is identical to that of the catheter 30 and others described above. When the catheter 40 is used to supply a drug solution into a vein of a patient A, the same procedure as described above may be performed, in which catheter 30 or others were used to supply a drug solution into a vein of a patient A. Accordingly, because a plurality of valves 43a, 43b is provided, infusion of a drug solution or collection of blood through the valves 43a, 43b can be performed more reliably. Additionally, due to this catheter with valve 40, if for example, one among the plurality of valves 43a, 43b becomes clogged, infusion of a drug solution or collection of blood through other of the valves 43a, 43b can still be performed.

When blood flows from the outside toward the inside of catheter 40, in either case, valves 43a open easily, and when a drug solution flows from the inside toward the outside of catheter 40, valves 43b open easily. As a result, when a drug solution flows from the inside toward the outside, and when blood flows from the outside toward the inside of catheter 40, in either case, the flow of drug solution or blood may be made smooth. Other operational effects of catheter 40 are similar to the operational effects of catheter 30 and others described above.

The catheters of the present disclosure are not limited to the individual embodiments described above and may be implemented with suitable modifications. For example, bidirectional deformation parts 35, 35a of catheters 30, 30a, respectively, are provided by forming oblique surfaces at the outer circumference or inner circumference of portions opposed across slit 34, 34a, such that the sides defining slits 34, 34a gradually become thin-walled; however, a bidirectional deformation part may also be provided by forming oblique surfaces at both the outer circumference and the inner circumference.

A bidirectional deformation part can also be provided by forming a groove-shaped, thin-walled portion at a portion maintaining a predetermined interval from slit 34 or others, and a bidirectional deformation part can also be provided by making the entire circumference of slit 34 or others thin-walled. The number of bidirectional deformation parts when a plurality is provided is also not limited to 4; 3 or fewer or 5 or more are also acceptable, and individual bidirectional deformation parts with shapes differing suitably can also be used in combination. A bidirectional deformation part may also be provided by making the part more flexible than other portions of a catheter. The outer circumferential portion of a slit may also be made into a bidirectional deformation part by making the inner space eccentric, such that the portion of a catheter with valve where a slit is provided gradually becomes thinner-walled than other portions.

In addition to a polyurethane resin, the material used to comprise catheter 30 or others described above may be a silicone, nylon, or a polyvinyl chloride. Additionally, in the embodiments described above, a port 17 is connected to a base terminal 11 of a catheter 30 or others, but the base terminal 11 of catheter 30 or others may also be connected to a transfusion line. As discussed above, catheter 30 or others was placed in a vein, but a predetermined method may also be used to place catheter 30 or others in an artery.

Although specific features of the catheter with valve are shown in some of the drawings and not in others, this is for convenience only as each feature may be combined with any or all of the other features in accordance with the aspects of the present disclosure. Other embodiments will occur to those skilled in the art and are within the following claims.

Claims

1. A catheter comprising:

a tubular body having proximal and distal ends, and inner and outer surfaces;
at least one valve formed near the distal end of the tubular body, the valve being formed in the tubular body and including a deformation portion that defines a slit that is openable and closable, the deformation portion including an oblique surface defining the openable/closable slit, the oblique surface being formed at the outer surface of the tubular body, the openable/closable slit communicating from the inner surface to the outer surface of the tubular body, wherein the distance between the inner surface and the outer surface of the tubular body progressively becomes thinner approaching the openable/closable slit within the deformation portion.

2. The catheter of claim 1, wherein the deformation portion permits bidirectional flow through the slit.

3. The catheter of claim 1, wherein a wall of the tubular body is thinnest about the slit.

4. The catheter of claim 1, including two or more valves.

5. The catheter of claim 4, wherein the oblique surface of at least one of the two or more valves is formed on the inner surface of the tubular body.

6. A catheter comprising:

a tubular body having proximal and distal ends, and inner and outer surfaces;
a valve formed in the tubular body near the distal end of the tubular body, the valve including a deformation portion configured to permit bidirectional flow therethrough, the deformation portion including an oblique surface defining an openable/closable slit, the oblique surface being formed at the outer surface of the tubular body.

7. The catheter of claim 6, wherein the oblique surface is formed at the inner surface of the tubular body.

8. The catheter of claim 6, wherein a wall of the tubular body is thinnest about the slit.

9. The catheter of claim 6, including two or more valves.

10. The catheter of claim 9, wherein the oblique surface of at least one of the valves is formed on the inner surface of the tubular body and the oblique surface of at least one of the other valves is formed on the outer surface of the tubular body.

11. A catheter comprising:

a tubular body having proximal and distal ends, and inner and outer surfaces;
at least one valve formed in the tubular body near the distal end of the tubular body, the valve including a deformation portion having an oblique surface defining a slit that is openable and closable, the oblique surface being formed at the outer surface of the tubular body, the openable/closable slit communicating from the inner surface to the outer surface of the tubular body, wherein the distance between the inner surface and the outer surface of the tubular body progressively becomes thinner approaching the openable/closable slit within the deformation portion, the elongated body being thinnest about the elongated slit, wherein the deformation portion permits bidirectional flow though the elongated slit.
Referenced Cited
U.S. Patent Documents
4403983 September 13, 1983 Edelman et al.
4475898 October 9, 1984 Brodner et al.
4493696 January 15, 1985 Uldall
4549879 October 29, 1985 Groshong et al.
4568329 February 4, 1986 Mahurkar
4583968 April 22, 1986 Mahurkar
4619643 October 28, 1986 Bai
4626240 December 2, 1986 Edelman et al.
4643711 February 17, 1987 Bates
4671796 June 9, 1987 Groshong et al.
4692141 September 8, 1987 Mahurkar
4701166 October 20, 1987 Groshong et al.
4737152 April 12, 1988 Alchas
4753640 June 28, 1988 Nichols et al.
4769005 September 6, 1988 Ginsburg et al.
4772268 September 20, 1988 Bates
4772269 September 20, 1988 Twardowski et al.
4795439 January 3, 1989 Guest
4808155 February 28, 1989 Mahurkar
4808156 February 28, 1989 Dean
4813934 March 21, 1989 Engelson et al.
4842582 June 27, 1989 Mahurkar
4895561 January 23, 1990 Mahurkar
4897079 January 30, 1990 Zaleski et al.
4961809 October 9, 1990 Martin
4973319 November 27, 1990 Melsky
4995863 February 26, 1991 Nichols et al.
4995865 February 26, 1991 Gahara et al.
5009636 April 23, 1991 Wortley et al.
5035399 July 30, 1991 Rantanen-Lee
5041083 August 20, 1991 Tsuchida et al.
5053004 October 1, 1991 Market et al.
5053023 October 1, 1991 Martin
5057073 October 15, 1991 Martin
5059170 October 22, 1991 Cameron
5085632 February 4, 1992 Ikada et al.
5106368 April 21, 1992 Uldall et al.
5112301 May 12, 1992 Fenton, Jr. et al.
5135599 August 4, 1992 Martin et al.
5147332 September 15, 1992 Moorehead
5156592 October 20, 1992 Martin et al.
5160325 November 3, 1992 Nichols et al.
5167623 December 1, 1992 Cianci et al.
5188593 February 23, 1993 Martin
5190520 March 2, 1993 Fenton, Jr. et al.
5195962 March 23, 1993 Martin et al.
5197951 March 30, 1993 Mahurkar
5209723 May 11, 1993 Twardowski et al.
5219335 June 15, 1993 Willard et al.
5221255 June 22, 1993 Mahurkar et al.
5221256 June 22, 1993 Mahurkar
5224938 July 6, 1993 Fenton, Jr.
5250034 October 5, 1993 Appling et al.
5261885 November 16, 1993 Lui
5267979 December 7, 1993 Appling et al.
5304155 April 19, 1994 Lui
5308338 May 3, 1994 Helfrich
5346471 September 13, 1994 Raulerson
5348536 September 20, 1994 Young et al.
5360397 November 1, 1994 Pinchuk
5364344 November 15, 1994 Beattie et al.
5374245 December 20, 1994 Mahurkar
5378230 January 3, 1995 Mahurkar
5380276 January 10, 1995 Miller et al.
5395316 March 7, 1995 Martin
5403291 April 4, 1995 Abrahamson
5405341 April 11, 1995 Martin
5451206 September 19, 1995 Young
5464398 November 7, 1995 Haindl
5472417 December 5, 1995 Martin et al.
5480380 January 2, 1996 Martin
5486159 January 23, 1996 Mahurkar
5489278 February 6, 1996 Abrahamson
5509897 April 23, 1996 Twardowski et al.
5522807 June 4, 1996 Luther
5531679 July 2, 1996 Schulman et al.
5554136 September 10, 1996 Luther
5556390 September 17, 1996 Hicks
5569182 October 29, 1996 Twardowski et al.
5571093 November 5, 1996 Cruz et al.
D381420 July 22, 1997 Musgrave et al.
D384411 September 30, 1997 Musgrave et al.
D384741 October 7, 1997 Musgrave et al.
5683640 November 4, 1997 Miller et al.
5685867 November 11, 1997 Twardowski et al.
5702365 December 30, 1997 King
5718678 February 17, 1998 Fleming, III
5776096 July 7, 1998 Fields
5797869 August 25, 1998 Martin et al.
5807311 September 15, 1998 Palestrant
5807329 September 15, 1998 Gelman
5807349 September 15, 1998 Person et al.
5810789 September 22, 1998 Powers et al.
5830184 November 3, 1998 Basta
5830196 November 3, 1998 Hicks
5868717 February 9, 1999 Prosl
5928203 July 27, 1999 Davey et al.
5947953 September 7, 1999 Ash et al.
5961485 October 5, 1999 Martin
5961486 October 5, 1999 Twardowski et al.
5968009 October 19, 1999 Siman
5976103 November 2, 1999 Martin
5984903 November 16, 1999 Nadal
5989206 November 23, 1999 Prosl et al.
5989213 November 23, 1999 Maginot
5993437 November 30, 1999 Raoz
6001079 December 14, 1999 Pourchez
6004310 December 21, 1999 Bardsley et al.
6099519 August 8, 2000 Olsen et al.
6123725 September 26, 2000 Aboul-Hosn
6126631 October 3, 2000 Loggie
6146354 November 14, 2000 Beil
6156016 December 5, 2000 Maginot
6190349 February 20, 2001 Ash et al.
6190371 February 20, 2001 Maginot et al.
6206849 March 27, 2001 Martin et al.
6273875 August 14, 2001 Siman et al.
6280423 August 28, 2001 Davey et al.
6293927 September 25, 2001 McGuckin, Jr.
6342120 January 29, 2002 Basta
6346090 February 12, 2002 Liska et al.
6394141 May 28, 2002 Wages et al.
6409700 June 25, 2002 Siegel, Jr. et al.
6447488 September 10, 2002 Estabrook et al.
6461321 October 8, 2002 Quinn
6475207 November 5, 2002 Maginot et al.
6482169 November 19, 2002 Kuhle
6506182 January 14, 2003 Estabrook et al.
6569145 May 27, 2003 Shmulewitz et al.
6579261 June 17, 2003 Kawamura
6585705 July 1, 2003 Maginot et al.
6592542 July 15, 2003 Childers et al.
6592558 July 15, 2003 Quah
6595966 July 22, 2003 Davey et al.
6620118 September 16, 2003 Prosl et al.
6638242 October 28, 2003 Wilson et al.
6692473 February 17, 2004 St. Cyr et al.
6695832 February 24, 2004 Schon et al.
6719749 April 13, 2004 Schweikert et al.
6723075 April 20, 2004 Davey et al.
6723084 April 20, 2004 Maginot et al.
6730096 May 4, 2004 Basta
6743218 June 1, 2004 Maginot et al.
6749580 June 15, 2004 Work et al.
6758836 July 6, 2004 Zawacki
6786884 September 7, 2004 DeCant, Jr. et al.
6808510 October 26, 2004 DiFiore
6814718 November 9, 2004 McGuckin, Jr. et al.
6858019 February 22, 2005 McGuckin, Jr. et al.
6872198 March 29, 2005 Wilson et al.
6911014 June 28, 2005 Wentling et al.
6921396 July 26, 2005 Wilson et al.
6942635 September 13, 2005 Rosenblatt et al.
6942653 September 13, 2005 Quinn
6966886 November 22, 2005 Appling
6969381 November 29, 2005 Voorhees
6976973 December 20, 2005 Ruddell et al.
6986752 January 17, 2006 McGuckin, Jr. et al.
6991625 January 31, 2006 Gately et al.
7008395 March 7, 2006 Loggie
7008412 March 7, 2006 Maginot
7011645 March 14, 2006 McGuckin, Jr. et al.
7013928 March 21, 2006 Navis
7048680 May 23, 2006 Viole et al.
7066914 June 27, 2006 Andersen
7077829 July 18, 2006 McGuckin, Jr. et al.
7413564 August 19, 2008 Morris et al.
7491192 February 17, 2009 DiFiore
20020121282 September 5, 2002 McGuskin, Jr. et al.
20020156430 October 24, 2002 Haarala et al.
20030032918 February 13, 2003 Quinn
20030093029 May 15, 2003 McGuckin, Jr. et al.
20030191425 October 9, 2003 Rosenblatt
20040249337 December 9, 2004 DiFiore
20050033222 February 10, 2005 Haggstrom et al.
20050043703 February 24, 2005 Nordgren
20050085765 April 21, 2005 Voorhees
20050090776 April 28, 2005 McGuckin, Jr. et al.
20050215978 September 29, 2005 Ash
20050228339 October 13, 2005 Clark
20050256509 November 17, 2005 Sakai
20050267400 December 1, 2005 Haarala et al.
20050288623 December 29, 2005 Hjalmarsson
20060004325 January 5, 2006 Hamatake et al.
20060149191 July 6, 2006 DiFiore
20060253063 November 9, 2006 Schweikert
20070100298 May 3, 2007 Appling
20070219527 September 20, 2007 Barron
20070225678 September 27, 2007 Lui
20090312718 December 17, 2009 Onuma
20100081986 April 1, 2010 Matson
Foreign Patent Documents
0 299 622 January 1989 EP
0 299 622 January 1989 EP
0 554 722 August 1993 EP
0 322 225 February 1995 EP
0 713 406 March 1998 EP
0864336 September 1998 EP
0 864 336 March 1999 EP
0 570 530 August 1999 EP
0 555 780 September 1999 EP
1595565 November 2005 EP
1 144 039 December 2005 EP
207-175297 July 2007 JP
WO 95/04567 February 1995 WO
WO 97/37699 October 1997 WO
WO 98/41277 September 1998 WO
WO 99/38550 August 1999 WO
WO 99/65557 December 1999 WO
WO 00/06239 February 2000 WO
WO 01/91845 December 2001 WO
WO 02/13899 February 2002 WO
WO 02/18004 March 2002 WO
WO 03/033049 April 2003 WO
WO 03/066148 August 2003 WO
WO 2004/093956 November 2004 WO
WO 2005/023336 March 2005 WO
WO 2005/077449 August 2005 WO
WO 2005/084741 September 2005 WO
WO 2006/014339 February 2006 WO
Other references
  • Extended European Search Report corresponding to EP Application No. 09 17 0662, completed Jan. 11, 2010; mailed Jan. 27, 2010 (7 pages).
  • Extended European Search Report issued by the European Patent Office and completed on Sep. 22, 2009 in co-pending European Patent Application No. EP 09251289.6.
Patent History
Patent number: 8864724
Type: Grant
Filed: May 8, 2009
Date of Patent: Oct 21, 2014
Patent Publication Number: 20090312718
Assignee: Covidien LP (Mansfield, MA)
Inventor: Tadatsugu Onuma (Fukuroi)
Primary Examiner: Emily Schmidt
Assistant Examiner: Michael J Anderson
Application Number: 12/463,019
Classifications
Current U.S. Class: Means For Controlling Material Flow To Or From Body, Or Metering A Predetermined Dose Or Amount (604/246); Having Fluid Responsive Means (e.g., Check Valve, Etc.) (604/247)
International Classification: A61M 25/14 (20060101); A61M 25/00 (20060101);